CRTh2 antagonist
This page covers all CRTh2 antagonist drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting CRTh2.
Targets
Phase 2 pipeline (1)
- ARRY-502, CRTh2 antagonist; oral · Pfizer · Immunology
Blocks CRTh2 receptor to reduce inflammation.
Patent intelligence
- crth2 antagonist patent landscape — aggregated cliff calendar, attackable patents, originator estates